Our pipeline

A focused portfolio.
A far-reaching ambition.

Explore an illustrative development portfolio for established Kernicterus. Every candidate, mechanism, and stage below is hypothetical.

Development portfolio

Follow the possibilities.

PROGRAM / FOCUS

DiscoveryPreclinicalPhase 1Phase 2Phase 3

KT-101

Neural circuit modulation

Motor function

Phase 1

KT-201

Auditory pathway support

Auditory function

Preclinical

KT-301

Regenerative biology

Neural repair

Discovery

Illustrative portfolio and stages · Fictional candidates · No clinical outcomes or approvals claimed.

Select a program arrow to explore its rationale, imagined next step, and scientific limitations. Development stages do not imply successful results.

Illustrative lead program / KT-101

Start with the signal.
Keep function in view.

PHASE 1 · HYPOTHETICAL

A circuit-focused approach to motor function.

KT-101 is an invented small-molecule candidate concept exploring whether modulation of surviving neural circuits could support motor function after bilirubin injury.

In the imagined Phase 1 setting, the first questions concern safety, tolerability, and exposure. There are no actual trial results, enrollment opportunities, or efficacy claims.

Build what comes next

A different future takes all of us.

Bring a discovery. Share a perspective. Help move the field forward.

Explore partnership ↗

A focused portfolio.A far-reaching ambition.